Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels [Phase 1]
A Phase 1 clinical trial evaluated whether gastric bypass surgery affects blood levels of the antidepressant venlafaxine ER.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms [Phase 2]
Phase 2 trial sponsored by the University of Miami evaluating a coping-with-peer-victimization intervention to reduce anxious and depressed …
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD) [Phase 3]
A Phase 3 feasibility study evaluating PH94B nasal spray for acute treatment of social anxiety disorder has completed.
-
FDA approval · 2015-09-16FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for fluvoxamine maleate (generic) from Endo USA, Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-09-11Clinical Trial Update: Dysfunctional Attention Processes in Fear of Blushing: Specificity and Changeability [NA]
A completed clinical trial from Technische Universität Dresden investigates dysfunctional attention processes in fear of blushing associated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia [Phase 3]
Phase 3 trial evaluating D-cycloserine plus cognitive behavioral therapy for social anxiety disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Efficacy of a Mindfulness Meditation Program for Social Anxiety Disorder [NA]
This update reports the completion of a clinical trial evaluating the efficacy of a mindfulness meditation program for social anxiety disord…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Mindfulness and Acceptance-Based Treatments for Social Anxiety: Defusion App [NA]
Completed clinical trial evaluating mindfulness- and acceptance-based treatments delivered through a Defusion App for social anxiety.
-
FDA approval · 2015-06-09FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride (generic) from Quallent Pharmaceuticals Health LLC under ANDA077397.
-
FDA approval · 2015-05-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved Yaopharma Co., Ltd.'s original application for venlafaxine hydrochloride, authorizing a new generic version of the antidepressa…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
A completed clinical trial examined brain markers in youth with anxiety disorders and the effects of SSRI treatment and cognitive-behavioral…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Attention Bias Modification Treatment for Children With Social Anxiety [Phase 2]
Phase 2 clinical trial update on Attention Bias Modification Treatment for children with social anxiety disorder; the study status is comple…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Predictors of Exposure Success in Public Speaking Anxiety
A completed University of California, San Diego study examined factors that predict successful exposure therapy for performance anxiety.
-
FDA approval · 2015-05-01FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism [NA]
A completed clinical trial evaluated cognitive behavioral therapy for anxiety disorders in adolescents with autism, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Acamprosate in Alcoholics With Comorbid Anxiety or Depression [Phase 4]
Phase 4 study evaluating acamprosate in individuals with alcohol use disorder and coexisting anxiety or depressive disorders; results have b…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Virtual Reality Exposure Therapy for the Treatment of Social Phobia [NA]
This publication notes the completion of a clinical trial evaluating virtual reality exposure therapy for social anxiety disorder conducted …
-
FDA approval · 2014-12-17FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC. The action is to modify labelin…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder [NA]
A completed UCLA-led clinical trial examining long-term effects and neural mediators of behavioral treatments for Social Anxiety Disorder.
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder [Phase 3]
A phase 3 open-label pilot trial evaluating memantine as augmentation therapy for generalized anxiety disorder and social anxiety disorder, …
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Cognitive Biases Modification Treatment for Social Anxiety [Phase 2]
Phase 2 trial evaluating cognitive biases modification treatment for social anxiety disorder has completed.
-
FDA approval · 2014-12-01FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC, adding or updating labeling under the existing NDA.
-
FDA approval · 2014-11-26FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for PAROXETINE (paroxetine hydrochloride) from Zydus Lifesciences Limited, enabling the marketing of…
-
FDA approval · 2014-11-17FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approval of a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, confirming regulatory action on this generic …
-
FDA approval · 2014-11-07FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s generic sertraline hydrochloride under an Original Application (ANDA 202825).